Avian influenza viruses replicate in a variety of mammals and birds, yet hemagglutination inhibition tests show that postinfection sera from these animals (e.g., ferrets and ducks) have insignificant levels of antibodies (Hinshaw et al., Infect. Immun. 34:354-361, 1981) . This suggested that avian influenza viruses, in contrast to mammalian viruses, may not induce a significant humoral response. Studies reported here indicate that avian influenza viruses do induce high levels of antibodies in ferrets, ducks, and mice and produce long-lived memory for cytotoxic T-cells in mice. The failure to detect hemagglutination-inhibiting antibodies to avian viruses was explained by the finding that antibodies to avian influenza viruses were not detectable in hemagglutination inhibition tests with intact virus yet were readily demonstrable when hemagglutinin subunits were used. In addition, these sera contained high levels of neutralizing antibodies to the avian virus. These findings suggest that the hemagglutinins of avian and mammalian influenza viruses may differ in their accessibility to antibodies or the biological consequence of antibody attachment or both. The practical consequence of these studies is that hemagglutination inhibition tests with intact avian viruses fail to detect antibody and do not correlate with virus neutralization. The avian virus used in these studies, A/Mallard/NY/6870/78 (H2N2), replicated and caused mortality in BALB/c mice, emphasizing that the host range and virulence of avian viruses extends to mammals. The above findings suggest that avian viruses could infect mammals in nature, yet seroepidemiological studies with conventional hemagglutination inhibition tests could give misleading results.
The major reservoir of influenza A viruses in nature is in avian species; 8 of the 13 different hemagglutinin (HA) subtypes are found only in birds, and the remaining 5 subtypes are shared by virus isolates from both birds and mammals (25) . Epidemiologically, avian influenza viruses are important, for they have been implicated in the origin of some genes in H2N2 and H3N2 human pandemic strains (18, 22) and have been associated with disease outbreaks in domestic animals (4). The recent appearance of an avianlike influenza virus in seals has suggested that avian viruses can infect and produce disease in mammals in nature (12, 20) .
Studies on the replication of avian viruses have shown that these viruses infect and replicate in a variety of lower mammals, e.g., pigs, cats, hamsters, ferrets, squirrel monkeys, and mink, as well as in birds (10, 16, 17) . The level of virus replication and disease symptoms varies depending on both the virus and the host involved. One feature that both birds and mam-mals have in common, however, is a poor antibody response after infection. Studies on the serological response of ducks experimentally infected with avian influenza viruses indicated that little or no antibody was produced, yet the ducks were immune to reinfection (9, 11) . The serological response of ferrets after infection with avian influenza virus was also lower than the response after infection with mammalian strains (10) . One possible explanation for these findings is that avian viruses induce a restricted humoral response and that protection is due to cell-mediated immunity. Alternatively, the assay system used for measuring humoral antibody may be inadequate. A mouse model system was therefore established to investigate both arms of the immune response to avian influenza viruses.
These studies established that avian influenza viruses do induce humoral antibodies in mice, ferrets, and ducks and also induce long-lived cytotoxic T-cell memory in mice. The failure to detect humoral antibodies was associated with the finding that antibodies to avian influenza viruses frequently do not inhibit hemagglutina-tion of intact virions. During development of the mouse model system, it also became apparent that the avian influenza virus used replicated and caused mortality in mice.
MATERIALS AND METHODS Viruses. The following strains of influenza A viruses were used in these studies: Japan/305/57 (H2N2) (Jap/ 305), Udorn/307/72 (H3N2) (Udorn), Mallard/New York/6750/78 (H2N2) (Mallard), and Seal/Mass/1/80 (H7N7) (Seal). The recombinant strains, A/Mallard/ New York/6750/78 (H2)-Bel/42 (N1) (R) and A/Jap/305/ 57 (H2)-Bel/42 (N1) (R), were prepared as described previously (19) .
The Udorn strain was kindly provided by Brian Murphy, National Institutes of Health, Bethesda, Md., and other strains were from the repository at St. Jude Children's Research Hospital, Memphis, Tenn. The Mallard strain was plaque purified twice in primary chicken kidney cells prepared from Spafas embryos (17) and grown once in 11-day-old chicken embryos. The Seal strain was a second egg passage from the original field isolate. The viruses were grown in 11-day-old chicken embryos and purified by adsorption to and elution from chicken erythrocytes followed by differential centrifugation and sedimentation through a sucrose gradient (10 to 40%o sucrose, 0.15 M NaCl) (13) . Some of the purified viruses were inactivated with Formalin and standardized in a single radial diffusion system to contain a known amount of HA protein (23) .
Isolated HA subunits. HA was isolated from recombinant influenza viruses as described previously (14) . Briefly, purified virus was disrupted with sodium dodecyl sulfate, the proteins were separated by electrophoresis on cellulose acetate, and, after elution, the protein was precipitated with ethanol.
Infection of animals. Groups of BALB/c mice (6 to 8 weeks old) were anesthetized with pentobarbital sodium (Abbott Laboratories) and inoculated intranasally with approximately 106 50%o egg infective dose (EID50) of virus in 0.05 ml. At daily intervals, mice were bled and sacrificed; the lungs were removed, ground in powdered glass, and titrated for virus in 11-day-old embryonated eggs (8) . Pekin white ducks (2 months of age) were infected orally with approximately 106 EID50 of influenza virus (9) . Ferrets (4 to 6 months old) were infected intranasally with approximately 106 EIDo of virus as described previously (10).
Serological assays. Hemagglutination inhibition (HI)
tests with receptor-destroying enzyme-treated sera were done as described previously (6) . Neuraminidase inhibition assays were done as recommended by the World Health Organization (24) . Neutralization tests were done by titrating virus infectivity in the presence of preinfection and postinfection sera. Briefly, serial 10-fold dilutions of virus were mixed with equal volumes of a 1:20 dilution of serum which had been heat inactivated at 56°C for 30 min. After incubation at 4°C for 30 min, the serum-virus mixtures were inoculated into five embryonated eggs per dilution. The eggs were then tested for HA activity after 48 h at 35°C to determine virus titer (EID50 per milliliter). Neutralization activities were expressed as neutralization indices, i.e., the difference in virus titers in the presence of preinfection versus postinfection sera.
Cell-mediated immunity assays. BALB/c (H-2d) mice were infected as described above, and cytotoxic Tcells were generated in vitro as previously described (26 
RESULTS

Replication of influenza viruses in mice.
To compare the immune response to different influenza viruses after infection, it was first necessary to examine the replication of these viruses in mice. BALB/c mice were infected with Mallard, Seal, and human influenza viruses (Fig. 1) . The human and Seal viruses replicated and reached peak titers on day 1 postinfection (p.i.), and shedding continued for the next 7 days. In contrast, Mallard virus grew to a 100-fold lower peak titer, which was reached on day 4 p.i., yet virus was shed for 8 days.
Although the Mallard virus replicated to lower levels than the Seal or Udom strains, it nevertheless caused significant mortality in mice (Table 1). Examination of the lungs of mice for gross pathological changes revealed that, on day 4 after infection with Mallard virus, the lungs showed at least 50% consolidation. In contrast, mice infected with Seal or Udorn viruses showed no significant consolidation at this time. It could be argued that the high input of infectious virus used in these studies was responsible for the mortality; mice were therefore infected with a 1,000-fold lower dose of Mallard virus, and in this experiment 50% of the mice died on day 4 p.i. (Table 4) . Antisera from mice, ferrets, and ducks Replication of influenza viruses in mice. that had been infected with Mallard virus or tfBALB/c mice were infected as described in immunized with Formalin-treated virus had low Two mice were killed each day, and infec-titers of HI antibodies to intact Mallard virus Is from the lungs was titrated in embryonated but, when HA subunits were used as antigen, much higher levels of HI antibodies were detected, levels similar to those obtained with the intact human H2N2 strain. In contrast, there agh the replication and disease induced was no significant difference in HI antibody imalian and avian viruses differed in titers with intact virus or HA subunits of Jap/305 was clear that all strains grew; thus, the (H2N2) ( Table 4) . model was suitable for examining the These results could be interpreted to mean response to different strains. that antibodies to avian influenza viruses cannot gical response of mice infected with influ-gain access to antigenic determinants on intact uses. The HI test has traditionally been virions. This explanation is unlikely, since anti-,t widely accepted assay for detecting bodies to Mallard virus effectively neutralized es to influenza viruses. This test was the infectivity of the homologous intact virus e used to study the antibody responses (Table 4) . These antibodies also neutralized the infected with avian and human influenza related Jap/305 (H2N2) strain, but to much lower Table 2 ). The mice infected with Udorn titers. The antibodies induced by Formalin-/305 viruses produced high levels of treated avian influenza viruses effectively inhib-(, but the HI antibody responses to ited the HI activity of isolated HA, but were less avian and Seal viruses were so low that they were insignificant (HI titer < 1:20). These results are consistent with the failure to detect HI antibodies in ducks and ferrets after infection with avian strains (9-11) and could be interpreted to mean that antibodies were not induced. However, when sera from mice infected with Mallard virus were tested for HI activity with the antigenically related human strain (Jap/305), high levels of antibodies were detected (Table  3 ). These studies indicate that mice do produce antibodies to avian influenza viruses, but these antibodies fail to inhibit the homologous avian strain in HI assays.
Detection of antibodies to avian strains with isolated HA subunits. The above studies indicated that the failure to detect antibodies to the avian influenza virus was a property of the assay system. Previous studies have shown that the When the present studies were initiated, it seemed possible that the cell-mediated response to avian viruses, rather than humoral antibodies, was responsible for immunity of infected animals. The studies described above established that antibodies were induced after infection and suggested that avian viruses differed from mammalian strains in their presentation of antigenic determinants on the HA molecule. This raised the question as to whether the cell-mediated responses to avian and mammalian viruses might also differ. To examine this possibility, the induction of specific and cross-reactive T-cell populations in mice infected with avian and mammalian viruses was studied. The kinetics of primary cytotoxic T-cell induction in BALB/c mice were the same for the Mallard, Seal, and human strains tested (results not shown). Studies on cytotoxic T-cells from these mice after secondary in vitro stimulation also showed no differences between the responses to avian or mammalian viruses (Fig. 2) . Both specific and cross-reactive populations of cytotoxic T-cell lymphocytes were induced and were long lived; high levels of activity were detected 8.5 months after infection (Fig. 2) . inhibit the HA of intact avian viruses is that the avian virus particles may be larger and more pleomorphic than the human strains, requiring more antibody molecules to inhibit hemagglutination. Electron microscopic examination of the human and avian strains used in this study revealed that they were equally pleomorphic, suggesting that this explanation is untenable. A second possibility is that antigenic determinants on intact virions are masked in some way, e.g., by glycosylation, but this seems unlikely, since isolation of HA subunits with detergent would not be expected to alter the configuration of the carbohydrate residues. A third possibility is that the determinants are located lower down on the stalk of the HA monomer, so that attachment of antibodies to such determinants "in vivo" may require processing of the HA to expose these determinants. In HI tests, these antibodies may combine with the determinants but fail to inhibit binding of erythrocytes. A fourth possibility is that the antibodies may be of low affinity, but this is unlikely, since they efficiently neutralize infectivity. Another possibility is that the lack of HI activity may be related to the species of erythrocytes used in the assay; this will be investigated in later studies. Whatever the mechanism, it is clear that avian influenza viruses differ from mammalian strains in this property. The practical consequence of this finding is that HI assays with intact avian influenza viruses would give erroneous results when used in seroepidemiological studies.
It is apparent that avian influenza viruses do induce both humoral and cell-mediated responses and that cross-protection can be detected between different human and avian subtypes of influenza viruses. In this regard, the response of mice to avian viruses correlates with responses to mammalian strains (5) .
The mortality in BALB/c mice caused by the nonadapted avian strain was unexpected, for other studies with the Mallard virus (17) in hamsters, ferrets, and squirrel monkeys have shown that this virus is restricted in its replication in mammals and causes no mortality. The genetic basis for interhost variation is not understood, but it is apparent that differences do exist. This study with mice again emphasizes that the host range of avian influenza virus is not limited to birds and could be important in creating conditions for genetic exchange between influenza viruses.
